Literature DB >> 15521979

DHCR7 mutations and genotype-phenotype correlation in 37 Polish patients with Smith-Lemli-Opitz syndrome.

E Ciara1, M J M Nowaczyk, M Witsch-Baumgartner, E Malunowicz, E Popowska, A Jezela-Stanek, M Piotrowicz, J S Waye, G Utermann, M Krajewska-Walasek.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive disorder of cholesterol biosynthesis caused by mutations in the DHCR7 gene. Thirty-seven ethnic Polish patients with SLOS underwent mutation analysis. The mutation frequencies in Polish patients were significantly different from those observed in Western European populations. Two mutations, W151X (22/68 alleles, 32%) and V326L (19/68 alleles, 28%), accounted for 60% of all observed in our cohort. Two missense mutations L68P and L360P have not been reported previously. In total, we report 15 DHCR7 mutations identified in Polish patients. By comparing clinical severity scores and the biochemical and molecular data, a genotype-phenotype correlation was attempted. In compound heterozygotes with one null mutation, the phenotype severity depends on the localization and type of the second mutation: mild phenotypes are correlated with mutations affecting the putative transmembrane domains TM1-TM6 or CT regions and severe phenotypes with mutations localized in TM7 and 4L region. The phenotypic differences of patients with the same genotype suggest that severity of the disease may be affected by other factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521979     DOI: 10.1111/j.1399-0004.2004.00350.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  Smith-Lemli-Opitz syndrome with a classical phenotype, oesophageal achalasia and borderline plasma sterol concentrations.

Authors:  D Haas; S Armbrust; J-P Haas; J Zschocke; K Mühlmann; C Fusch; L M Neumann
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Birthday of a syndrome: 50 years anniversary of Smith-Lemli-Opitz Syndrome.

Authors:  Martina Witsch-Baumgartner; Barbara Lanthaler
Journal:  Eur J Hum Genet       Date:  2014-05-14       Impact factor: 4.246

Review 3.  Smith-Lemli-Opitz syndrome.

Authors:  Andrea E DeBarber; Yasemen Eroglu; Louise S Merkens; Anuradha S Pappu; Robert D Steiner
Journal:  Expert Rev Mol Med       Date:  2011-07-22       Impact factor: 5.600

Review 4.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models.

Authors:  Roman Chrast; Gesine Saher; Klaus-Armin Nave; Mark H G Verheijen
Journal:  J Lipid Res       Date:  2010-11-09       Impact factor: 5.922

5.  Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS).

Authors:  D Haas; S F Garbade; C Vohwinkel; N Muschol; F K Trefz; J M Penzien; J Zschocke; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-05-11       Impact factor: 4.982

6.  Maternal ABCA1 genotype is associated with severity of Smith-Lemli-Opitz syndrome and with viability of patients homozygous for null mutations.

Authors:  Barbara Lanthaler; Elisabeth Steichen-Gersdorf; Barbara Kollerits; Johannes Zschocke; Martina Witsch-Baumgartner
Journal:  Eur J Hum Genet       Date:  2012-08-29       Impact factor: 4.246

Review 7.  Cyclopia (synophthalmia) in Smith-Lemli-Opitz syndrome: First reported case and consideration of mechanism.

Authors:  David D Weaver; Benjamin D Solomon; Kelly Akin-Samson; Richard I Kelley; Maximilian Muenke
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

8.  Phenotypic severity in a family with MEND syndrome is directly associated with the accumulation of potentially functional variants of cholesterol homeostasis genes.

Authors:  María Carmen Barboza-Cerda; Oralia Barboza-Quintana; Gerardo Martínez-Aldape; Raquel Garza-Guajardo; Miguel Angel Déctor
Journal:  Mol Genet Genomic Med       Date:  2019-08-08       Impact factor: 2.183

9.  Smith-Lemli-Opitz syndrome - Fetal phenotypes with special reference to the syndrome-specific internal malformation pattern.

Authors:  Katharina Schoner; Martina Witsch-Baumgartner; Jana Behunova; Robert Petrovic; Rainer Bald; Susanne G Kircher; Annette Ramaswamy; Britta Kluge; Matthias Meyer-Wittkopf; Ralf Schmitz; Barbara Fritz; Johannes Zschocke; Franco Laccone; Helga Rehder
Journal:  Birth Defects Res       Date:  2019-12-16       Impact factor: 2.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.